Novel mutations in the sacsin gene in ataxia patients from Maritime Canada
Received 20 March 2009; received in revised form 24 September 2009; accepted 29 September 2009. published online 05 November 2009.
Abstract
We ascertained two families in Eastern Canada segregating a form of ataxia consistent with a recessive mode of inheritance. We performed a whole genome scan using dense SNP genotyping, and despite an absence of shared homozygosity in the families we defined linkage to a small region on chromosome 13. Direct DNA resequencing was employed to screen biologically relevant candidate genes in the interval, and two presumptive pathogenic mutations were found in the gene encoding sacsin. One variant is an obligate truncating mutation, the second is a missense variant in a highly conserved residue. Unexpectedly, one family was homozygous for the missense mutation, the other compound heterozygous for the two mutations. Our results expand the genotype phenotype correlation of mutations in the sacsin gene, and highlight the challenge of diagnosing genetically heterogeneous disorders on primarily clinical grounds. We demonstrate that whole genome genotyping on a modest scale can be productive in research, and potentially in a clinical context.
aDepartment of Pathology, Dalhousie University, Halifax, NS, Canada
bMontreal Heart Institute, Montreal, Quebec, Canada
cDepartment of Medicine, Université de Montréal, Montreal, Quebec, Canada
dMaritime Medical Genetics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada
eDepartment of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada
fBruce Lefroy Center for Genetic Health Research, Murdoch Children's Research Institute, Genetic Health Services, Royal Children's Hospital, Victoria, Australia
gDepartment of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada
Corresponding author. Centre de Recherche du CHU Ste-Justine, Local A-733, 3175, Côte Ste-Catherine, Montréal QC, Canada H3T 1C5. Tel.: +1 514 345 4931 p4265; fax: +1 514 345 4801.